CN101829143A - 含有硅酸的挤出物的制备方法、所述的挤出物、其应用和含有所述挤出物的药物组合物 - Google Patents

含有硅酸的挤出物的制备方法、所述的挤出物、其应用和含有所述挤出物的药物组合物 Download PDF

Info

Publication number
CN101829143A
CN101829143A CN201010144554A CN201010144554A CN101829143A CN 101829143 A CN101829143 A CN 101829143A CN 201010144554 A CN201010144554 A CN 201010144554A CN 201010144554 A CN201010144554 A CN 201010144554A CN 101829143 A CN101829143 A CN 101829143A
Authority
CN
China
Prior art keywords
extrudate
silicic acid
carrier
acid
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201010144554A
Other languages
English (en)
Chinese (zh)
Inventor
D·A·R·范登比尔格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Minerals NV
Original Assignee
Bio Minerals NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Minerals NV filed Critical Bio Minerals NV
Publication of CN101829143A publication Critical patent/CN101829143A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/20—Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
CN201010144554A 2002-08-12 2003-08-12 含有硅酸的挤出物的制备方法、所述的挤出物、其应用和含有所述挤出物的药物组合物 Pending CN101829143A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02078336A EP1391426A1 (en) 2002-08-12 2002-08-12 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
EP02078336.1 2002-08-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNA03820875XA Division CN1678524A (zh) 2002-08-12 2003-08-12 含有硅酸的挤出物的制备方法、所述的挤出物、其应用和含有所述挤出物的药物组合物

Publications (1)

Publication Number Publication Date
CN101829143A true CN101829143A (zh) 2010-09-15

Family

ID=30775855

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201010144554A Pending CN101829143A (zh) 2002-08-12 2003-08-12 含有硅酸的挤出物的制备方法、所述的挤出物、其应用和含有所述挤出物的药物组合物
CNA03820875XA Pending CN1678524A (zh) 2002-08-12 2003-08-12 含有硅酸的挤出物的制备方法、所述的挤出物、其应用和含有所述挤出物的药物组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA03820875XA Pending CN1678524A (zh) 2002-08-12 2003-08-12 含有硅酸的挤出物的制备方法、所述的挤出物、其应用和含有所述挤出物的药物组合物

Country Status (15)

Country Link
US (2) US8771757B2 (cg-RX-API-DMAC7.html)
EP (2) EP1391426A1 (cg-RX-API-DMAC7.html)
JP (2) JP4727227B2 (cg-RX-API-DMAC7.html)
CN (2) CN101829143A (cg-RX-API-DMAC7.html)
AT (1) ATE428404T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003266283B2 (cg-RX-API-DMAC7.html)
CA (1) CA2494165C (cg-RX-API-DMAC7.html)
CY (1) CY1109228T1 (cg-RX-API-DMAC7.html)
DE (1) DE60327231D1 (cg-RX-API-DMAC7.html)
DK (1) DK1551763T3 (cg-RX-API-DMAC7.html)
ES (1) ES2325254T3 (cg-RX-API-DMAC7.html)
IL (2) IL166779A0 (cg-RX-API-DMAC7.html)
PT (1) PT1551763E (cg-RX-API-DMAC7.html)
SI (1) SI1551763T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004016551A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113271927A (zh) * 2018-11-09 2021-08-17 生物矿物股份有限公司 水溶性含硅颗粒

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1391426A1 (en) 2002-08-12 2004-02-25 Bio Minerals N.V. Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
ITMI20050093A1 (it) * 2005-01-25 2006-07-26 Unimer Spa Procedimento industriale per ottenere la granulazione di fertilizzanti mangimi e altri prodotti a partire da un procedimento preliminare di pellettatura
US7700083B2 (en) * 2005-10-24 2010-04-20 Kevin Meehan Skin care composition for accelerated production of collagen proteins and method of fabricating same
FR2909558B1 (fr) * 2006-12-12 2009-04-17 Ceva Sante Animale Sa Procede de fabrication de premelanges medicamenteux
ES2652114T3 (es) * 2007-10-15 2018-01-31 7 Oaks Pharmaceutical Corporation Una disolución que contiene silicato para uso en el tratamiento de melanoma
GB0720423D0 (en) * 2007-10-19 2007-11-28 Univ Leuven Kath Method for brewing beer
GB0805279D0 (en) 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
WO2009127256A1 (en) * 2008-04-17 2009-10-22 Jisbrey, S.A Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use
CZ2008841A3 (cs) * 2008-12-23 2010-07-28 Agra Group, A.S. Pivo a nápoje na bázi piva a zpusob úpravy obsahu polyfenolu a kremíku v nich
GB0913255D0 (en) 2009-07-30 2009-09-02 Sisaf Ltd Topical composition
DE102010008981A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie
DE102010008982A1 (de) 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie
WO2012032364A1 (en) 2010-09-06 2012-03-15 Creogen D.O.O. Stabilized solution of ortho-silicic acid based on salicylic acid as effective inhibitor of its polymerization, its preparation and use
WO2012035364A1 (en) 2010-09-15 2012-03-22 Creogen D.O.O. Stabilized solution of ortho-silicic acid, its preparation and use
US10986647B2 (en) 2017-05-04 2021-04-20 At&T Intellectual Property I, L.P. Management of group common downlink control channels in a wireless communications system
CN107988292B (zh) * 2018-01-18 2023-12-26 江苏江山聚源生物技术有限公司 提高重组人源胶原蛋白稳定性的发酵工艺
EP3549578A1 (en) * 2018-04-06 2019-10-09 Bio Minerals N.V. Silicic acid formulation and use thereof
EP3632449A1 (en) 2018-10-05 2020-04-08 Bio Minerals N.V. Silicic acids for use in the treatment of periodontitis
PL3662761T3 (pl) * 2018-12-04 2021-11-02 Dsm Ip Assets B.V. Stabilne podczas przechowywania adsorbaty związków nitrooksy
EP3714879A1 (en) 2019-03-28 2020-09-30 Sisaf Ltd Structured encapsulated silicon-containing particles
GB201904337D0 (en) 2019-03-28 2019-05-15 Sisaf Ltd A delivery system
GB201904334D0 (en) 2019-03-28 2019-05-15 Sisaf Ltd Carrier system for preparing herbaceous extracts
GB201904336D0 (en) 2019-03-28 2019-05-15 Sisaf Ltd A delivery system
WO2020260413A1 (fr) 2019-06-28 2020-12-30 Tilman Sa Composition comprenant au moins un triterpène et/ou au moins un triterpénoïde et/ou au moins une de leurs formes glycosylées
GB202104173D0 (en) * 2021-03-24 2021-05-05 Ab Vista Animal feed composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9400189A (nl) 1994-02-07 1995-09-01 Bio Pharma Sciences Bv Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat.
FR2799758B1 (fr) * 1999-10-15 2002-05-17 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation
EP1110909A1 (en) * 1999-12-24 2001-06-27 Bio Minerals N.V. Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use
EP1391426A1 (en) 2002-08-12 2004-02-25 Bio Minerals N.V. Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113271927A (zh) * 2018-11-09 2021-08-17 生物矿物股份有限公司 水溶性含硅颗粒
TWI888363B (zh) * 2018-11-09 2025-07-01 比利時商生物礦物股份有限公司 水溶性含矽顆粒

Also Published As

Publication number Publication date
US20060099276A1 (en) 2006-05-11
AU2003266283A1 (en) 2004-03-03
CA2494165A1 (en) 2004-02-26
US20140255493A1 (en) 2014-09-11
US8945617B2 (en) 2015-02-03
EP1391426A1 (en) 2004-02-25
JP4727227B2 (ja) 2011-07-20
CN1678524A (zh) 2005-10-05
DE60327231D1 (de) 2009-05-28
SI1551763T1 (sl) 2009-10-31
WO2004016551A1 (en) 2004-02-26
CY1109228T1 (el) 2014-07-02
EP1551763B1 (en) 2009-04-15
JP2010265309A (ja) 2010-11-25
US8771757B2 (en) 2014-07-08
PT1551763E (pt) 2009-07-07
AU2003266283B2 (en) 2008-04-10
EP1551763A1 (en) 2005-07-13
ES2325254T3 (es) 2009-08-31
DK1551763T3 (da) 2009-07-20
JP2005535549A (ja) 2005-11-24
CA2494165C (en) 2009-05-26
IL166779A (en) 2010-05-17
ATE428404T1 (de) 2009-05-15
IL166779A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
CN1678524A (zh) 含有硅酸的挤出物的制备方法、所述的挤出物、其应用和含有所述挤出物的药物组合物
KR101635186B1 (ko) 활성 소분자 귀경 혼합물 및 그의 제조방법, 그리고 그의 응용
CN104105492B (zh) 具有抗炎活性的发酵鹿茸提取物的制备方法、由此得到的提取物及该提取物的用途
JP4505707B2 (ja) 血管拡張による肩凝り又は冷え症治療用の医薬組成物
CN102105154A (zh) 含有水提取硫酸软骨素和槲皮素糖苷的口服给药用制剂
CN1961957A (zh) 一种抗衰老结肠吸收制剂
CN110881555A (zh) 一种具有双降作用的分散糖果片
CN1496741A (zh) 生产含异麦芽酮糖的肠道营养素的方法
JPWO2014119605A1 (ja) ビフィズス菌を含有する安定な組成物
CN1942183A (zh) 含有异山梨醇的凝胶制剂
CN101028098B (zh) 含有骨胶原肽的食品组合物
CN110935007A (zh) 利那洛肽复方组合物、制剂及其用途和制备方法
CN117338730A (zh) 一种糜蛋白酶口服冻干粉散剂及其制备方法
CN116672355A (zh) 一种羧甲基木聚糖锌络合物在保健药物或食品中的应用
CN1823764A (zh) 一种含有雷奈酸锶和维生素d药物组合物
CN108157974A (zh) 一种胎盘寡肽益生菌复合制剂及其制备方法
CN106858614A (zh) 复合氨基酸硒酵母口服液
CN1168273A (zh) 蜂蛹钙制剂
TW200826962A (en) Oral solid composition masking bitterness
JP5270893B2 (ja) 異味成分を含有する速崩壊性顆粒の製造方法
CN117982533B (zh) 一种复合钙制剂及其生产工艺
JP3993907B2 (ja) カルシウム吸収促進剤
CN1129452C (zh) 表皮生长因子口含片
CN1634073A (zh) 左氧氟沙星或其药用盐的口腔崩解片
CN1522711A (zh) 含有肠内细菌的片剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100915